What are the responsibilities and job description for the Assistant/Associate Dean for Clinical and Translational Research, Tulane School of Medicine >>> position at Tulane University School of Medicine?
Tulane University School of Medicine (Tulane SoM) seeks candidates for the newly created position of Dean of Clinical and Translational Research. The Assistant/Associate Dean will be an accomplished scientist and visionary leader in funded clinical research with experience working within a matrixed academic environment.
The Assistant/Associate Dean will be expected to enhance and deepen research collaborations with the Tulane School of Medicine, health system and cross-university initiatives. This position will also be accountable for the growth and development of the Tulane Center for Clinical Research (TCCR). A key responsibility for this role will be the creation of a strategic plan that features clinical impact, competitive analysis, business plans, and performance management. The overarching approach will be to synergize the many elements needed to conduct the full-range of clinical trials from Phase 1 to Phase 4, bench to bedside, investigator-initiated to industry- or federally sponsored research. Strategically, this individual will primarily focus on evaluation of the current competitive environment and landscape to assess strengths, opportunities, and weaknesses in order to build research prowess with industry sponsors in pharmaceuticals and biotechnology.
The Assistant/Associate Dean will be expected to enhance and deepen research collaborations with the Tulane School of Medicine, health system and cross-university initiatives. This position will also be accountable for the growth and development of the Tulane Center for Clinical Research (TCCR). A key responsibility for this role will be the creation of a strategic plan that features clinical impact, competitive analysis, business plans, and performance management. The overarching approach will be to synergize the many elements needed to conduct the full-range of clinical trials from Phase 1 to Phase 4, bench to bedside, investigator-initiated to industry- or federally sponsored research. Strategically, this individual will primarily focus on evaluation of the current competitive environment and landscape to assess strengths, opportunities, and weaknesses in order to build research prowess with industry sponsors in pharmaceuticals and biotechnology.
